Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Bryan Baranowski, MD, is an electrophysiologist and invasive cardiologist in the Section of Electrophysiology and Pacing in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, specializing in the diagnosis and management of heart rhythm disorders. He was appointed to the medical staff in 2009. His areas of expertise include catheter ablation of complex arrhythmias and pulmonary vein isolation for atrial fibrillation, as well as device related therapies including the implantation and extraction of pacemakers, defibrillators and CRT-D devices.
A graduate of Vanderbilt University School of Medicine, Dr. Baranowski served his internship and residency at Johns Hopkins Medical Center, Baltimore, Md. He has been at Cleveland Clinic since 2004, completing a fellowship in cardiovascular medicine here, followed by a fellowship in electrophysiology. During his final fellowship year he served as the Chief Clinical Fellow in Electrophysiology.
In addition to his clinical practice, Dr. Baranowski is actively engaged in cardiovascular research. His interests include electrical therapies for heart failure and ventricular dyssynchrony, and novel therapeutic approaches to patients with rhythm disorders including atrial fibrillation.
Dr. Baranowski is the co-author of a number of articles appearing in scientific and medical journals, including a recent his latest paper on the use of a robotic system for atrial fibrillation ablation. He also has had numerous abstracts and presentations at the scientific meetings of the American Heart Association, American College of Cardiology and the Heart Rhythm Society to his credit, as well as a book chapter in Manual of Cardiovascular Medicine by Brian Griffin, MD and Eric Topol, MD.
Dr. Baranowski is board certified in internal medicine, cardiovascular medicine and clinical cardiac electrophysiology. He is a member of the Heart Rhythm Society and the American College of Cardiology.
Arrhythmias, Atrial Fibrillation, Cardiac Implantable Electronic Device Infection, Long QT Syndrome, Biventricular Pacemaker, Catheter Ablation, Electrophysiology Study, Implantable Cardioverter Defibrillation, Lead Extraction, Pulmonary Vein Isolation Ablation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/6/2015, Dr. Baranowski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.